Skip to main content

𝙇𝙑𝙃 𝙀𝙣 π™€π˜Ύπ™‚ – 𝙏𝙬𝙀 π˜½π™šπ™¨π™© π™ˆπ™šπ™©π™π™€π™™π™¨





Left Ventricular Hypertrophy (LVH) is a common finding in patients with long-standing hypertension, aortic stenosis, or other conditions that increase left ventricular workload. Detecting LVH on an electrocardiogram (ECG) is crucial for identifying cardiac remodeling before structural heart disease becomes advanced. Although echocardiography remains the gold standard, ECG provides a fast and cost-effective screening tool.


---

What is LVH?

LVH refers to thickening of the left ventricular wall due to chronic pressure overload. On ECG, this manifests as increased QRS voltage and often secondary repolarization (strain) changes in the lateral leads.


---

Main ECG Criteria for LVH

1. Sokolow–Lyon Criteria

One of the oldest and simplest ECG criteria for LVH, mainly based on precordial lead voltages.

Formula:

S in V1 + R in V5 or V6 ≥ 35 mm (3.5 mV)
(Use the larger R wave between V5 and V6)


Optional additional criterion:

R in aVL ≥ 11 mm


Key Features:

Easy and quick to apply.

Best used in young, thin patients.

May overestimate LVH in lean individuals and underestimate it in obese or elderly patients.

Does not account for gender or age differences.




2. Cornell Criteria

Developed to improve the accuracy of voltage-based LVH detection by including both limb and chest leads, with adjustments for sex.

Formula:

R in aVL + S in V3 > 28 mm (men)

R in aVL + S in V3 > 20 mm (women)


Key Features:

More specific than Sokolow–Lyon.

Accounts for body and gender differences.

Reliable for both limb and chest lead analysis.

Cornell Voltage–Duration Product enhances accuracy:
(R in aVL + S in V3) × QRS duration > 2440 mm·ms indicates LVH.

---

Other Supportive ECG Findings

Left axis deviation

Left atrial enlargement

ST segment depression and T-wave inversion (“strain pattern”) in lateral leads

Prolonged QRS duration


These findings reinforce the suspicion of LVH but are not diagnostic by themselves.


---

Clinical Significance

LVH on ECG is not just a voltage change—it is a marker of cardiac risk. Patients with ECG evidence of LVH have higher rates of arrhythmia, heart failure, and sudden cardiac death. Recognizing it early allows for timely control of hypertension and other contributing factors.

---

Takeaway:
ECG remains an invaluable first step in detecting LVH. The Sokolow–Lyon criterion is simple and traditional, while the Cornell criterion offers better accuracy and clinical reliability. Confirm findings with echocardiography, and always interpret ECG voltages in the context of the patient’s body build and clinical history.


---

#LVH #ECG #SokolowLyon #CornellCriteria #Cardiology #Hypertension #HeartHealth #Electrocardiogram #CardiacRisk #Echo


Thanks 😊 

Comments

Popular posts from this blog

Learn Echocardiography | Standard Protocol for Performing Comprehensive Echocardiogram | Explained with Images and Videos

  If you are just starting to learn echocardiography, you will find that learning the full echo examination protocol will be immensely useful. The full protocol will provide a solid foundation for your career in echo. I personally found that once I could execute the standard protocol flawlessly, I was able to add and refine additional echo scanning skills while deepening my understanding of the purpose of each echo image. The echo protocol illustrated in this article is the same one we currently use for all our patients in the hospital and meets or exceeds the standards of American Society of Echocardiography (ASE) for an adult echocardiography examination. The protocol presented here is meant as a guideline and does not cover every aspect (such as off axis views) of an echo examination. Also other hospitals will probably have slight variations of this protocol depending on the lab's needs, which is normal. This article's main purpose is to provide a solid foundation for ...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

What is Duke treadmill Score (DTS) and How to calculate it?

Watch this simple video on DTS calculation with example case:   Commonly asked questions: How to Calculate Duke treadmill Score? What is DTS? How to risk stratify a patient with ETT (Exercise Tolerance Test)? #Cardiology #Non-Invasive risk Stratification